Hywel Dda Health Board
13
2
2
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Comparison of Longer-term (5 Year+) Outcomes (Survival) of Smokers, Ex-smokers, Never Smoker and Quitters
Role: lead
Is Community Based Monitoring of Diabetic Maculopathy and Pre-proliferative Diabetic Retinopathy Safe?
Role: lead
Investigating the Metabolic and Lipidomic Profiles That Are Associated With Varying Grades of Diabetic Maculopathy and Retinopathy in South Wales
Role: lead
Ultrasound and Attenuation Imaging
Role: lead
Left Atrial Strain Values as an Early Predictor of Atrial Fibrillation
Role: lead
COPD Pal Phase 1: A Self-management App in COPD
Role: lead
sTep dOWn Inhalers in the reAl woRlD
Role: lead
Optimisation of Exercise Intensity During High-Intensity Interval Training for Glucose Control in Prediabetes
Role: collaborator
Medication Monitoring for Older Adults in Primary Care
Role: collaborator
15-minute Individual Consultation to Improve Blood Glucose Control in Pre-diabetes
Role: collaborator
Do Educational Digital Films Enhance Patient COPD Outcomes?
Role: collaborator
Exercise and Neutrophil Function in COPD
Role: lead
New Markers to Measure Clotting in Patients With the Obstructive Sleep Apnoea Hypopnoea Syndrome
Role: lead
All 13 trials loaded